398458-55-4

Upstream product

• 77398-20-0 methyl-3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside 
• 18977-93-0 L-Daunosamine hydrochloride 
• 122-04-3 4-nitro-benzoyl chloride 

Downstream Products

• 398458-56-5 4-Nitro-benzoic acid (2S,3S,4S,6R)-6-[3-(2-methoxycarbonyl-ethyl)-1,2,3,4-tetrahydro-naphthalen-1-yloxy]-2-methyl-4-(4-nitro-benzoylamino)-tetrahydro-pyran-3-yl ester 
• 398458-57-6 4-Nitro-benzoic acid (2S,3S,4S,6R)-2-methyl-4-(4-nitro-benzoylamino)-6-(1,2,3,4-tetrahydro-naphthalen-1-yloxy)-tetrahydro-pyran-3-yl ester 

Relevant academic research and scientific papers

Synthesis of a new hapten for generating catalytic antibodies that activate doxorubicin prodrugs

In order to assess a novel strategy for catalytic activation of a new prodrug of doxorubicin, a new hapten has been designed and prepared, which can be used to induce an immune response from which catalytic antibodies (cAbs) may be produced.